Towards predictive computational models of oncolytic virus therapy: Basis for experimental validation and model selection

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Wodarz, Dominik ^a   Komarova, Natalia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

ARTICLE; CANCER CONTROL; CELL COMMUNICATION; COMPUTATIONAL MODEL; MATHEMATICAL MODEL; ONCOLYTIC VIROTHERAPY; OUTCOME ASSESSMENT; VIROGENESIS; VIRUS REPLICATION; ADENOVIRUS; ANIMAL; BIOLOGICAL MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MOUSE; NEOPLASM; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; VIRUS REPLICATION;

EID: 63049110384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004271     Document Type: Article

References (39)

1. Kirn DH, McCormick F (1996) Replicating viruses as selective cancer therapeutics. Mol Med Today 2: 519-527.
2. Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE (2007) Oncolytic viruses in cancer therapy. Cancer Lett.
3. Crompton AM, Kirn DH (2007) From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 7: 133-139.
4. Bell JC, Lichty B, Stojdl D (2003) Getting oncolytic virus therapies off the ground. Cancer Cell 4: 7-11.
5. Bell JC (2007) Oncolytic viruses: what's next? Curr Cancer Drug Targets 7: 127-131.
6. Kelly E, Russell SJ (2007) History of oncolytic viruses: genesis to genetic engineering. Mol Ther 15: 651-659.
7. Roberts MS, Lorence RM, Groene WS, Bamat MK (2006) Naturally oncolytic viruses. Curr Opin Mol Ther 8: 314-321.
8. Post DE, Shim H, Toussaint-Smith E, Van Meir EG (2005) Cancer scene investigation: how a cold virus became a tumor killer. Future Oncol 1: 247-258.
9. McCormick F (2005) Future prospects for oncolytic therapy. Oncogene 24: 7817-7819.
10. McCormick F (2003) Cancer-specific viruses and the development of ONYX-015. Cancer Biol Ther 2: S157-160.
11. O'Shea CC (2005) Viruses - seeking and destroying the tumor program. Oncogene 24: 7640-7655.
12. Parato KA, Senger D, Forsyth PA, Bell JC (2005) Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5: 965-976.
13. Davis JJ, Fang B (2005) Oncolytic virotherapy for cancer treatment: challenges and solutions. J Gene Med 7: 1380-1389.
14. Kaplan JM (2005) Adenovirus-based cancer gene therapy. Curr Gene Ther 5: 595-605.
15. Lorence RM, Pecora AL, Major PP, Hotte SJ, Laurie SA, et al. (2003) Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Curr Opin Mol Ther 5: 618-624.
16. Aghi M, Martuza RL (2005) Oncolytic viral therapies - the clinical experience. Oncogene 24: 7802-7816.
17. Wodarz D (2003) Gene Therapy for Killing p53-Negative Cancer Cells: Use of Replicating Versus Nonreplicating Agents. Hum Gene Ther 14: 153-159.
18. Wodarz D (2001) Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Res 61: 3501-3507.
19. Wodarz D (2004) Computational approaches to study oncolytic virus therapy: insights and challenges. Gene therapy and molecular biology 8: 137-146.
20. Novozhilov AS, Berezovskaya FS, Koonin EV, Karev GP (2006) Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models. Biol Direct 1: 6.
21. Friedman A, Tian JP, Fulci G, Chiocca EA, Wang J (2006) Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res 66: 2314-2319.
22. Nowak MA, May RM (2000) Virus dynamics. Mathematical principles of immunology and virology. Oxford University Press.
23. Anderson RM, May RM (1991) Infectious diseases of humans. Oxofrd, England: Oxfors University Press.
24. Adam JA, Bellomo N, eds (1997) A survey of models for tumor-immune system dynamics. Boston, Basel, Berlin: Birkenhauser.
25. McCallum H, Barlow N, Hone J (2001) How should pathogen transmission be modelled? Trends Ecol Evol 16: 295-300.
26. Begon M, Hazel SM, Baxby D, Bown K, Cavanagh R, et al. (1999) Transmission dynamics of a zoonotic pathogen within and between wildlife host species. Proc Biol Sci 266: 1939-1945.
27. Adam JA, Bellomo N (1997) A survey of models for tumor-immune system dynamics. Boston: Birkhauser. 344 p.
28. Harrison D, Sauthoff H, Heitner S, Jagirdar J, Rom WN, et al. (2001) Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved- deletion of the viral E1b-19-kD gene increases the viral oncolytic effect. Hum Gene Ther 12: 1323-1332.
29. Bansal S, Grenfell BT, Meyers LA (2007) When individual behaviour matters: homogeneous and network models in epidemiology. J R Soc Interface 4: 879-891.
30. Barbour A, Mollison D (1990) Epidemics and random graphs. In: Gabriel JP, Lefevre C, Picard P, eds. Stochastic processes in epidemic theory. New York, NY: Springer.
31. Watts DJ, Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393: 440-442.
32. Pastor-Satorras R, Vespignani A (2001) Epidemic dynamics and endemic states in complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 63: 066117.
33. Newman ME (2002) Spread of epidemic disease on networks. Phys Rev E Stat Nonlin Soft Matter Phys 66: 016128.
34. Shirley MD, Rushton SP (2005) The impacts of network topology on disease spread. Ecol Complex 2.
35. May RM, Lloyd AL (2001) Infection dynamics on scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys 64: 066112.
36. Dezso Z, Barabasi AL (2002) Halting viruses in scale-free networks. Phys Rev E Stat Nonlin Soft Matter Phys 65: 055103.
37. Chahlavi A, Todo T, Martuza RL, Rabkin SD (1999) Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. Neoplasia 1: 162-169.
38. Korn WM, Macal M, Christian C, Lacher MD, McMillan A, et al. (2006) Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation. Cancer Gene Ther 13: 792-797.
39. Goodrum FD, Ornelles DA (1997) The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J Virol 71: 548-561.